By Gwenaëlle Douaud, et al. With comment from Dr. Bob Rufsvold The research from the UK is a worrisome tip-of-the-iceberg indicator, one that goes beyond our current understanding of “Long COVID” symptoms that many people are experiencing.Bob Rufsvold MD Abstract...
Researchers in Israel developed a COVID calculator to predict anyone’s chance of getting hospitalized with COVID-19 or dying from it once infected. Dr. Ariel Israel MD, Ph.D., et. al. created the calculator, the basis for which is published as a preprint...
By Venice Servellita, et al. PREPrint ~ August 25, 2021 with Commentary from TrialSiteNews Below Abstract Associations between vaccine breakthrough cases and infection by SARS coronavirus 2 (SARS-CoV-2) variants have remained largely unexplored. Here we analyzed...
By Hoai Thi Thu Tran ~ PREPrint article ~ March 19, 2021 ~ & Review below Abstract On 11th March 2020, coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, was declared as a global pandemic by the World Health Organization (WHO). To date, there are...
A group of researchers led by scientists at National Jewish Health, Denver, Colorado, and collaborators from China recently uploaded the results of their study to the preprint server bioRxiv. With a focus on the Lambda variant of interest, the study team recognized...
A group of researchers affiliated with the Rockefeller University in New York recently uploaded a study to the preprint server bioRxiv, meaning the works aren’t peer-reviewed as yet. Their study indicates that some people can have “superhuman immunity,” individuals...
By Sivan Gazit, et al. Abstract Background Reports of waning vaccine-induced immunity against COVID-19 have begun to surface. With that, the comparable long-term protection conferred by previous infection with SARS-CoV-2 remains unclear. Methods We conducted...
June 15, 2021 ~ MedRxiv ~ Gwenaëlle Douaud et al. Brain imaging before and after COVID-19 in UK Biobank Abstract There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain...
June 5, 2021 ~ MedRxiv ~ by Nabin K. Shrestha et al. Necessity of COVID-19 vaccination in previously infected individuals ABSTRACT Background The purpose of this study was to evaluate the necessity of COVID-19 vaccination in persons previously infected with...
By Jaroslav Flegr Summary Background Latent toxoplasmosis, i.e. a lifelong infection with the protozoan parasite Toxoplasma gondii, affects about a third of human population worldwide. In the past ten years, numerous studies had shown that infected...
https://www.cdc.gov/mmwr/volumes/70/wr/mm7013e2.htm?s_cid=mm7013e2_w Originally published by: CDC Author: Anjel Vahratian, et al. Date: 4/2/2021 Categories: Integrative Therapies,Recovery,Long Haul
By Long Chi Nguyen, et al. PREPRINT Abstract The rapid spread of COVID-19 underscores the need for new treatments. Here we report that cannabidiol (CBD), a compound produced by the cannabis plant, inhibits SARS-CoV-2 infection. CBD and its metabolite, 7-OH-CBD, but...
https://www.medrxiv.org/content/10.1101/2021.01.26.21250420v1 Originally published by: MedRxiv Author: Castaneda-Sabogal et al. Date: 1/26/2021 Categories: Integrative Therapies,Treatment,Ivermectin
https://covid19criticalcare.com/wp-content/uploads/2020/11/FLCCC-Ivermectin-in-the-prophylaxis-and-Integrative Therapies,Treatment-of-COVID-19.pdf Originally published by: FLCCC Author: Pierre Kory, MD, et al. Date: 12/18/2020 Categories: Prevention,Integrative...
https://www.medrxiv.org/content/10.1101/2020.11.30.20236570v1.full Originally published by: MedRxIV Author: Kalfas, et al. Date: 12/4/2020 Categories: Integrative Therapies,Treatment,Ivermectin